Literature DB >> 10725096

Synthesis and characterization of poly(ethylene glycol)-insulin conjugates.

K Hinds1, J J Koh, L Joss, F Liu, M Baudys, S W Kim.   

Abstract

Human insulin was modified by covalent attachment of short-chain (750 and 2000 Da) methoxypoly (ethylene glycol) (mPEG) to the amino groups of either residue PheB1 or LysB29, resulting in four distinct conjugates: mPEG(750)-PheB1-insulin, mPEG(2000)-PheB1-insulin, mPEG(750)-LysB29-insulin, and mPEG(2000)-LysB29-insulin. Characterization of the conjugates by MALDI-TOF mass spectrometry and N-terminal protein sequence analyses verified that only a single polymer chain (750 or 2000 Da) was attached to the selected residue of interest (PheB1 or LysB29). Equilibrium sedimentation experiments were performed using analytical ultracentrifugation to quantitatively determine the association state(s) of insulin derivatives. In the concentration range studied, all four of the conjugates and Zn-free insulin exist as stable dimers while Zn(2+)-insulin was exclusively hexameric and Lispro was monomeric. In addition, insulin (conjugate) self-association was evaluated by circular dichroism in the near-ultraviolet wavelength range (320-250 nm). This independent method qualitatively suggests that mPEG-insulin conjugates behave similarly to Zn-free insulin in the concentration range studied and complements results from ultracentrifugation studies. The physical stability/resistance to fibrillation of mPEG-insulin conjugates in aqueous solution were assessed. The data proves that mPEG(750 and 2000)-PheB1-insulin conjugates are substantially more stable than controls but the mPEG(750 and 2000)-LysB29-insulin conjugates were only slightly more stable than commercially available preparations. Circular dichroism studies done in the far ultraviolet region confirm insulin's tertiary structure in aqueous solution is essentially conserved after mPEG conjugation. In vivo pharmacodynamic assays reveal that there is no loss in biological activity after conjugation of mPEG(750) to either position on the insulin B-chain. However, attachment of mPEG(2000) decreased the bioactivity of the conjugates to about 85% of Lilly's HumulinR formulation. The characterization presented in this paper provides strong testimony to the fact that attachment of mPEG to specific amino acid residues of insulin's B-chain improves the conjugates' physical stability without appreciable perturbations to its tertiary structure, self-association behavior, or in vivo biological activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10725096     DOI: 10.1021/bc9901189

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  17 in total

1.  Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting.

Authors:  Lin Zhu; Pooja Kate; Vladimir P Torchilin
Journal:  ACS Nano       Date:  2012-03-14       Impact factor: 15.881

Review 2.  Glucose-responsive insulin release: Analysis of mechanisms, formulations, and evaluation criteria.

Authors:  Jianhai Yang; Zhiqiang Cao
Journal:  J Control Release       Date:  2017-01-31       Impact factor: 9.776

3.  In situ growth of a PEG-like polymer from the C terminus of an intein fusion protein improves pharmacokinetics and tumor accumulation.

Authors:  Weiping Gao; Wenge Liu; Trine Christensen; Michael R Zalutsky; Ashutosh Chilkoti
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-01       Impact factor: 11.205

4.  Role of a novel excipient poly(ethylene glycol)-b-poly(L-histidine) in retention of physical stability of insulin in aqueous solutions.

Authors:  Ajay Taluja; You Han Bae
Journal:  Pharm Res       Date:  2007-03-24       Impact factor: 4.200

5.  Insulin self-association: effects on lung disposition kinetics in the airways of the isolated perfused rat lung (IPRL).

Authors:  Yinuo Pang; Masahiro Sakagami; Peter R Byron
Journal:  Pharm Res       Date:  2007-05-03       Impact factor: 4.200

6.  Synthesis, characterization and in vivo efficacy of PEGylated insulin for oral delivery with complexation hydrogels.

Authors:  Anthony D Tuesca; Collin Reiff; Jeffrey I Joseph; Anthony M Lowman
Journal:  Pharm Res       Date:  2009-01-15       Impact factor: 4.200

7.  Preparation and characterization of mono-PEGylated epidermal growth factor: evaluation of in vitro biologic activity.

Authors:  Haeshin Lee; Tae Gwan Park
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

8.  A comparison of protein quantitation assays for biopharmaceutical applications.

Authors:  J E Noble; A E Knight; A J Reason; A Di Matola; M J A Bailey
Journal:  Mol Biotechnol       Date:  2007-10       Impact factor: 2.695

9.  Conjugation with cationic cell-penetrating peptide increases pulmonary absorption of insulin.

Authors:  Leena N Patel; Jeffrey Wang; Kwang-Jin Kim; Zea Borok; Edward D Crandall; Wei-Chiang Shen
Journal:  Mol Pharm       Date:  2009 Mar-Apr       Impact factor: 4.939

10.  Improved pharmacokinetics and reduced antibody reactivity of lysostaphin conjugated to polyethylene glycol.

Authors:  Scott Walsh; Anjali Shah; James Mond
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.